(Q40372701)
Statements
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy (English)
Ronald Yap
Dorina Veliceasa
Urban Emmenegger
Robert S Kerbel
Laura M McKay